MAGELLAN LONGEVITY
HomeNutraceuticals & Cellular Energizers › Dr. Mercola Liposomal Vitamin D3

Dr. Mercola Liposomal Vitamin D3

Written and medically reviewed by , physiatrist · Last reviewed · How we grade
In one paragraph

Dr. Mercola Liposomal Vitamin D3, graded Moderate-evidence on Magellan — secondary analyses, however, produced genuinely interesting signals: about 12% lower cancer mortality with daily (not bolus) dosing in an individual-patient meta-analysis, a 22% lower rate of autoimmune disease in VITAL, fewer acute respiratory infections (greatest in deficient people), and. In vitamin-D-replete adults the biggest RCTs (VITAL, DO-HEALTH) were null for cancer, cardiovascular events, fractures and mortality.

Source: BMJ 2019, PMID 31405892 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: high

Nutraceuticals & Cellular Energizers17 PubMed citations
$21.99 typical listed price — check the live price on Amazon
View Dr. Mercola Liposomal Vitamin D3 on Amazon ↗   Open in the Magellan store →

What it is

Vitamin D3 (cholecalciferol) is a fat-soluble secosteroid that the skin synthesizes on exposure to ultraviolet-B light and that is also obtained from foods and supplements. It is converted in the liver to 25-hydroxyvitamin D (calcidiol), the main circulating marker of vitamin D status, and then to the active hormone calcitriol, which regulates calcium and phosphate homeostasis and bone metabolism and has broad effects on immune function. Because vitamin D3 is highly hydrophobic, its oral absorption depends on accompanying lipids; liposomal (phospholipid-encapsulated) formulations are marketed to improve bioavailability, and a small clinical study reported that a liposomal preparation raised blood calcidiol more rapidly than an oil-based formulation.

Its role in longevity

Large randomized trials and meta-analyses give a mixed picture. In generally healthy, vitamin-D-replete adults the two biggest trials were null on their primary endpoints: VITAL (25,871 people, 2,000 IU/day for a median 5.3 years) did not reduce invasive cancer, major cardiovascular events or death, and DO-HEALTH found no benefit for fractures, physical function or cognition in adults over 70. Secondary analyses, however, produced genuinely interesting signals: about 12% lower cancer mortality with daily (not bolus) dosing in an individual-patient meta-analysis, a 22% lower rate of autoimmune disease in VITAL, fewer acute respiratory infections (greatest in deficient people), and — in a 2025 VITAL substudy — preserved leukocyte telomere length over four years, the first large randomized signal on a biological-aging marker. These are ancillary findings that need replication, not reasons for high-dose use. Benefits are clearest in people who begin with low vitamin D status, pointing toward correcting deficiency rather than universal supplementation. This evidence describes vitamin D3 (cholecalciferol) and its measured blood levels rather than this specific commercial liposomal product.

The research

Peer-reviewed studies on the active compound — citations link to PubMed.

“Vitamin D supplementation was associated with a reduction in cancer mortality but not all-cause or cardiovascular mortality in this meta-analysis of randomised controlled trials.”
BMJ 2019 · PMID 31405892
“vitamin D administered daily reduced cancer mortality by 12 percent”
Ageing Res Rev 2023 · PMID 37004841
“Quantitative synthesis of human studies showed no significant effect of vit D intake for dysmenorrhea (2 studies, 44 vit D vs 44 placebo, mean -0.71, 95% CI -1.94, 0.51) and non-cyclic pelvic pain (2 studies, 42 vit D vs 38 placebo, mean 0.34, 95% CI -0.02, 0.71).”
Reprod Biol Endocrinol 2022 · PMID 36578019
“These findings suggest that antioxidant vitamins may alleviate pain in endometriosis patients by reducing inflammation.”
Reprod Biol Endocrinol 2023 · PMID 37644533
“Vitamin D supplementation reduced the risk of acute respiratory tract infection among all participants (adjusted odds ratio 0.88, 95% confidence interval 0.81 to 0.96; P for heterogeneity <0.001).”
BMJ 2017 · PMID 28202713
“The summary relative risk for mortality from any cause was 0.93 (95% confidence interval, 0.87-0.99).”
Arch Intern Med 2007 · PMID 17846391

Research describes the active mechanism and is not a claim about this specific product.

Educational information, not medical advice. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if pregnant, nursing, or taking medication.

More in Nutraceuticals & Cellular Energizers

Omega-3 EPA/DHA Fish Oil

Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…

Creatine Monohydrate

Across meta-analyses and randomized trials, creatine monohydrate combined with…

Astaxanthin Softgels

In humans, randomized trials and meta-analyses most consistently show that astaxanthin…

Zinc Picolinate

Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…

See all Nutraceuticals & Cellular Energizers →

FAQ

Does Dr. Mercola Liposomal Vitamin D3 have scientific evidence?

Yes — its active compound is linked to 17 peer-reviewed studies, summarized and cited above.

Where can I buy Dr. Mercola Liposomal Vitamin D3?

You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.

Is Dr. Mercola Liposomal Vitamin D3 safe?

Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.